000 02387nim a2200553 a 4500
001 HST8241
003 UkLoHST
006 m o h
007 cr nna||||||||
007 sr |mnnnnnzne|
008 211104s2021 enk|||||o||h||||||||eng d
028 5 0 _a8241
_bHenry Stewart Talks
035 _a(UkLoHST)4797
040 _aUkLoHST
_beng
_cUkLoHST
100 1 _aLandau, Nathaniel R.
_4spk
245 1 0 _aComparison of immune resilience induced by vaccination versus COVID recovery
_h[electronic resource] /
_cNed Landau.
260 _aLondon :
_bHenry Stewart Talks,
_c2021.
300 _a1 online resource (1 streaming audio file (14 min.)).
490 1 _aInterviews on Covid-19,
_x2056-452X
500 _aAudio interview.
500 _aTitle from title frames.
505 0 _aContents: The need to characterize vaccine-indued immunity in more detail -- Methods for comparison of convalescent versus vaccination-induced plasma -- Higher effectiveness of antibodies induced by mRNA vaccination -- Characteristics of the new lambda variant – implications for immune escape -- Mechanisms leading to the increased efficiency of vaccine-induced antibodies compared to those of recovered patients..
506 _aAccess restricted to subscribers.
538 _aMode of access: World Wide Web.
650 0 _aCOVID-19 (Disease)
_xImmunological aspects.
650 0 _aCOVID-19 (Disease)
_xVaccination.
650 0 _aViral antibodies.
650 0 _aViral vaccines.
650 2 _aAntibodies, Neutralizing
_ximmunology.
650 2 _aAntibodies, Viral
_ximmunology.
650 2 _aCOVID-19 Vaccines
_xadministration & dosage.
650 2 _aCOVID-19 Vaccines
_ximmunology.
650 2 _aCOVID-19
_ximmunology.
650 2 _aCOVID-19
_xprevention & control.
650 2 _aCOVID-19
_xtherapy.
650 2 _aImmunization.
650 2 _amRNA Vaccine.
650 2 _aMutation.
650 2 _aNeutralization Tests.
650 2 _aSARS-CoV-2
_xgenetics.
650 2 _aSARS-CoV-2
_xisolation & purification.
650 2 _aSARS-CoV-2
_xpathogenicity.
650 2 _aSerum
_ximmunology.
650 2 _aSpike Glycoprotein, Coronavirus
_ximmunology.
650 2 _aVaccination.
830 0 _aHenry Stewart talks.
_pBiomedical & life sciences collection.
_pInterviews on Covid-19.
856 4 0 _uhttps://hstalks.com/bs/4797/
856 4 2 _uhttps://hstalks.com/bs/p/1060/
_3Series
999 _c75661
_d75661